Focal NanoKnife ablation publication in BJUI

Professor Stricker’s latest data with a minimum of one-year follow-up of NanoKnife ablation to the prostate has now been accepted for publication.

This is the third publication on this area and will go online very shortly. It is confirmed that the safety and accuracy and the success rate of this technology, although over the period since it was introduced in 2013 there have been some modifications to improve accuracy. It appears to have, in the appropriate setting, an over 95% chance of eradication of the disease locally and almost no incontinence and minimal erectile dysfunction.